Our findings suggest that we can repurpose GLP-1 agonists as potent anti-hyperalgesic and anti-inflammatory drugs to treat neuropathic pain without serious side effects
Its long-lasting presence helps control appetite and blood sugar consistently throughout the day
We know that many, if not all of the symptoms associated with ME/CFS and FM such as fatigue, pain, cognitive problems, and mood issues can be produced by the brain
Alves, E., Ntungwe, E
[DOI] [PMC free article] [PubMed] [Google Scholar] 26.Look A.R.G., Wing R.R., Bolin P., Brancati F.L., Bray G.A., Clark J.M., et al
Phentermine has been FDA-approved since 1959 for short-term use (typically up to 12 weeks), whereas some GLP-1 medications, such as semaglutide and tirzepatide, are designed for ongoing, chronic weight management